NCT04554043View on ClinicalTrials.gov

The PK/PD Study of SHR7280 Tablets in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

September 28, 2021

Study Completion Date

September 28, 2021

Conditions
Healthy Subjects
Interventions
DRUG

SHR7280

treatment

DRUG

Placebo oral tablet

blank control

Trial Locations (1)

266000

Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04554043 - The PK/PD Study of SHR7280 Tablets in Healthy Subjects. | Biotech Hunter | Biotech Hunter